Online citations, reference lists, and bibliographies.
← Back to Search

Muscular Dystrophies Involving The Dystrophin-glycoprotein Complex: An Overview Of Current Mouse Models.

M. Durbeej, K. Campbell
Published 2002 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The dystrophin-glycoprotein complex (DGC) is a multisubunit complex that connects the cytoskeleton of a muscle fiber to its surrounding extracellular matrix. Mutations in the DGC disrupt the complex and lead to muscular dystrophy. There are a few naturally occurring animal models of DGC-associated muscular dystrophy (e.g. the dystrophin-deficient mdx mouse, dystrophic golden retriever dog, HFMD cat and the delta-sarcoglycan-deficient BIO 14.6 cardiomyopathic hamster) that share common genetic protein abnormalities similar to those of the human disease. However, the naturally occurring animal models only partially resemble human disease. In addition, no naturally occurring mouse models associated with loss of other DGC components are available. This has encouraged the generation of genetically engineered mouse models for DGC-linked muscular dystrophy. Not only have analyses of these mice led to a significant improvement in our understanding of the pathogenetic mechanisms for the development of muscular dystrophy, but they will also be immensely valuable tools for the development of novel therapeutic approaches for these incapacitating diseases.
This paper references
10.1073/PNAS.96.19.10723
Muscle degeneration without mechanical injury in sarcoglycan deficiency.
A. A. Hack (1999)
10.1073/PNAS.94.23.12413
Dystrobrevin and dystrophin: an interaction through coiled-coil motifs.
H. M. Sadoulet-Puccio (1997)
10.1523/JNEUROSCI.18-01-00128.1998
Interaction of Muscle and Brain Sodium Channels with Multiple Members of the Syntrophin Family of Dystrophin-Associated Proteins
S. H. Gee (1998)
10.1083/jcb.200105003
A stoichiometric complex of neurexins and dystroglycan in brain
S. Sugita (2001)
10.1016/0092-8674(92)90115-S
Integrins: Versatility, modulation, and signaling in cell adhesion
R. Hynes (1992)
10.1074/jbc.272.50.31221
Sarcospan, the 25-kDa Transmembrane Component of the Dystrophin-Glycoprotein Complex*
R. Crosbie (1997)
10.1074/jbc.274.53.38171
Sarcoglycan Isoforms in Skeletal Muscle*
L. Liu (1999)
10.1093/HMG/8.9.1589
Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice.
K. Araishi (1999)
10.1038/NG0598-79
Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice
Jill A. Rafael (1998)
10.1038/NG1194-297
Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene
H. Xu (1994)
10.1016/0092-8674(87)90579-4
Dystrophin: The protein product of the duchenne muscular dystrophy locus
E. Hoffman (1987)
Identification of alpha-syntrophin binding to syntrophin triplet, dystrophin, and utrophin.
B. Yang (1995)
Muscular dystrophies involving the dystrophin–glycoprotein complex Durbeej and Campbell 359
Missense Muscular dystrophies involving the dystrophin–glycoprotein complex Durbeej and Campbell 357 mutations in the adhalin gene linked to autosomal recessive muscular dystrophy
Sl Roberds (1994)
Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice
D Taverna (2001)
10.1126/science.270.5237.819
Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular Dystrophy
S. Noguchi (1995)
matrix linkage
V Straub (1995)
adhesion
DJ Burkin (1992)
10.1074/JBC.271.25.15160
Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells
Kenneth S. Song (1996)
10.1111/j.1469-7793.2000.t01-3-00457.x
The capacity of mdx mouse diaphragm muscle to do oscillatory work
E. D. Stevens (2000)
10.1093/HMG/9.7.1033
Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy.
M. Yoshida (2000)
10.1093/HMG/9.13.2019
Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions.
R. Crosbie (2000)
Non - muscle α - dystroglycan is involved in epithelial development
M Durbeej (1995)
10.1097/00019052-199810000-00006
The sarcoglycan complex in limb-girdle muscular dystrophy.
L. E. Lim (1998)
The mdx diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy
HL StedmanHSweeney (1991)
10.1016/0092-8674(94)90051-5
A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering
James T. Campanelll (1994)
10.1097/00019052-199704000-00016
Muscular dystrophies and the dystrophin-glycoprotein complex.
V. Straub (1997)
10.1016/S0014-5793(00)02018-4
Conservation of components of the dystrophin complex in Drosophila 1
M. J. Greener (2000)
Targeted disruption of the nitric oxide synthase gene
Pl Huang (1993)
10.1073/PNAS.41.12.1079
Dystrophia Muscularis: A HEREDITARY PRIMARY MYOPATHY IN THE HOUSE MOUSE.
A. M. Michelson (1955)
10.1073/pnas.121027598
Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI
O. Camacho Vanegas (2001)
10.1083/JCB.147.5.913
Loss of a-Type Lamin Expression Compromises Nuclear Envelope Integrity Leading to Muscular Dystrophy
T. Sullivan (1999)
10.1016/S0014-5793(98)00442-6
Caveolin‐3 is not an integral component of the dystrophin glycoprotein complex
R. Crosbie (1998)
10.1016/0092-8674(91)90035-W
Membrane organization of the dystrophin-glycoprotein complex
J. Ervasti (1991)
10.1083/JCB.122.4.809
A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin
J. Ervasti (1993)
Mutations in the fukutin - related protein identify limb - girdle muscular dystrophy 2 I as a milder allelic variant of congenital muscular dystrophy MDC 1 C
M Brockington (2001)
Utrophindystrophin-deficient mice as a model for Duchenne Muscular Dystrophy
Ae Deckoninck (1997)
10.1093/HMG/5.8.1149
Differential expression of dystrophin isoforms in strains of mdx mice with different mutations.
W. B. Im (1996)
10.1086/339083
Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene.
P. Frosk (2002)
10.1073/PNAS.98.3.1194
Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice.
L. Eklund (2001)
Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene.
H. Xu (1994)
10.1093/HMG/10.25.2851
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C.
M. Brockington (2001)
10.1093/HMG/7.13.2135
Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy.
P. Bonaldo (1998)
10.1073/PNAS.100501197
Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF.
D. Garry (2000)
10.1074/JBC.274.4.2193
α1-Syntrophin Gene Disruption Results in the Absence of Neuronal-type Nitric-oxide Synthase at the Sarcolemma but Does Not Induce Muscle Degeneration*
S. Kameya (1999)
10.1093/emboj/18.4.863
Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α‐dystroglycan and several extracellular matrix proteins
J. Talts (1999)
10.1093/HMG/6.5.747
Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain.
V. Allamand (1997)
10.1172/JCI11642
Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex.
R. Cohn (2001)
10.1083/jcb.143.3.849
Dystrophic Muscle in Mice Chimeric for Expression of α5 Integrin
D. Taverna (1998)
Deficiency of α-dystroglycan in muscle-eye-brain disease
鹿野 博亀 (2004)
10.1038/15519
Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses
P. D. Côté (1999)
10.1007/BF00687043
Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse
Y. Tanabe (2004)
Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
Y. Hayashi (2001)
10.1038/ng713
Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome
B. Moghadaszadeh (2001)
10.1038/345315A0
Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
J. Ervasti (1990)
10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T
Molecular basis of muscular dystrophies
R. Cohn (2000)
10.1083/JCB.142.6.1461
Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice
F. Duclos (1998)
10.1203/00006450-199904020-00141
Role for α-Dystrobrevin in the Pathogenesis of Dystrophin-Dependent Muscular Dystrophies
R. Grady (1999)
Molecular and genetic characterization of sarcospan : insights into sarcoglycan – sarcospan domains
CS Lebakken (2000)
Molecular basis of three muscular dystrophies : disruption of the cytoskeleton -
KP Campbell
10.1016/0092-8674(95)90344-5
Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage
K. Campbell (1995)
10.1038/ng1195-266
β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex
C. Bönnemann (1995)
A follow up study to [88 @BULLET@BULLET ]. Immunohistochemical and immunoblot analyses demonstrate that α-dystroglycan, but not β-dystroglycan is absent in skeletal muscle of MEB patients
Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus.
Y. Sunada (1994)
Interaction of brain and muscle sodium channels with multiple members of the syntrophin family of dystrophin - associated proteins
SH Gee (1998)
10.1038/sj.gt.3301247
Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient mice
V. Allamand (2000)
Molecular basis of three muscular dystrophies: disruption of the cytoskeleton-extracellular matrix linkage
Kp Campbell (1995)
10.1016/S0014-5793(97)01007-7
Laminin α2 chain‐null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)‐deficient congenital muscular dystrophy
Y. Miyagoe (1997)
10.1074/jbc.271.5.2724
The Three Human Syntrophin Genes Are Expressed in Diverse Tissues, Have Distinct Chromosomal Locations, and Each Bind to Dystrophin and Its Relatives (*)
A. H. Ahn (1996)
10.1093/OXFORDJOURNALS.JBCHEM.A123276
Glycoprotein complex anchoring dystrophin to sarcolemma.
M. Yoshida (1990)
10.1073/PNAS.250379497
Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy.
M. Sander (2000)
10.1016/S0092-8674(00)80532-2
Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular Dystrophy
A. Deconinck (1997)
Muscular dystrophies involving the dystrophin–glycoprotein complex Durbeej and Campbell 361
Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice
Dj Burkin (2001)
10.1006/DBIO.1996.8430
Transient expression of Dp140, a product of the Duchenne muscular dystrophy locus, during kidney tubulogenesis.
M. Durbeej (1997)
10.1016/0022-510X(90)90005-8
Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions
B. Weller (1990)
10.1016/S1097-2765(00)80410-4
Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E.
M. Durbeej (2000)
10.1016/S0022-510X(99)00012-X
Secondary reduction of α7B integrin in laminin α2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle
R. Cohn (1999)
The mdx diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy
H Stedman (1991)
10.1212/WNL.57.1.115
Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy
Y. Hayashi (2001)
10.1038/75500
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
P. Sarkar (2000)
10.1152/AJPCELL.2000.278.6.C1108
Skeletal muscle function and water permeability in aquaporin-4 deficient mice.
B. Yang (2000)
10.1038/NSB0198-19
Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels
J. Schultz (1998)
Laminin alpha 2 chain - null mutant mice by targeted disruption of the Lam 2 gene : a new model of merosin ( laminin 2 ) - deficient congenital muscular dystrophy
W Kuang (1997)
10.1074/JBC.270.10.4975
Identification of α-Syntrophin Binding to Syntrophin Triplet, Dystrophin, and Utrophin (*)
B. Yang (1995)
The Peter Emil Becker Award lecture 1998. The saga of congenital muscular dystrophy.
F. M. Tomé (1999)
10.1016/0896-6273(93)90338-R
The 87K postsynaptic membrane protein from torpedo is a protein-tyrosine kinase substrate homologous to dystrophin
K. Wagner (1993)
10.1074/jbc.274.37.26609
Biochemical Characterization of the Epithelial Dystroglycan Complex*
M. Durbeej (1999)
10.1016/S0092-8674(00)81708-0
A Role for Dystroglycan in Basement Membrane Assembly
M. Henry (1998)
10.1093/HMG/7.4.589
Dystrophins in vertebrates and invertebrates.
R. Roberts (1998)
10.1038/NG0498-365
Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy
C. Minetti (1998)
10.1083/JCB.146.4.801
Domains in the 1α Dynein Heavy Chain Required for Inner Arm Assembly and Flagellar Motility in Chlamydomonas
S. Myster (1999)
10.1093/HMG/8.7.1309
Structural and functional rescue of murine rod photoreceptors by human rhodopsin transgene.
Niamh McNally (1999)
Interaction of brain and muscle sodium channels with multiple members of the syntrophin family of dystrophinassociated proteins
Sh Gee (1998)
10.1083/JCB.152.6.1207
Enhanced Expression of the α7β1 Integrin Reduces Muscular Dystrophy and Restores Viability in Dystrophic Mice
D. Burkin (2001)
10.1093/HMG/4.3.329
Dp140: a novel 140 kDa CNS transcript from the dystrophin locus.
H. Lidov (1995)
10.1006/BBRC.1997.7328
Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
E. Araki (1997)
10.1093/HMG/7.5.823
mdx muscle pathology is independent of nNOS perturbation.
R. Crosbie (1998)
10.1074/jbc.M000439200
γ1- and γ2-Syntrophins, Two Novel Dystrophin-binding Proteins Localized in Neuronal Cells*
G. Piluso (2000)
SH 3 domain mediated interaction of dystroglycan and Grb 2
B Yang (1995)
Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy.
Y. Miyagoe (1997)
10.1074/jbc.274.12.7907
Ecto-ATPase Activity of α-Sarcoglycan (Adhalin)*
R. Betto (1999)
10.1074/jbc.274.39.27989
ε-Sarcoglycan Replaces α-Sarcoglycan in Smooth Muscle to Form a Unique Dystrophin-Glycoprotein Complex*
V. Straub (1999)
10.1177/002215549804600404
Distribution of Dystroglycan in Normal Adult Mouse Tissues
M. Durbeej (1998)
10.1016/0896-6273(93)90157-M
Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution
M. Adams (1993)
10.1212/WNL.56.8.1059
Clinical and genetic distinction between Walker–Warburg syndrome and muscle–eye–brain disease
B. Cormand (2001)
Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies.
B. L. Hodges (1997)
Altered expression of the α7β1 integrin in human and murine muscular dystrophies
B. L. Hodges (1997)
10.1007/s004410051279
The α7β1 integrin in muscle development and disease
D. Burkin (1999)
10.1016/S0022-510X(99)00051-9
Immunocytochemical studies of aquaporin 4 in the skeletal muscle of mdx mouse
J. Liu (1999)
10.1074/jbc.271.50.32321
Characterization of δ-Sarcoglycan, a Novel Component of the Oligomeric Sarcoglycan Complex Involved in Limb-Girdle Muscular Dystrophy*
D. Jung (1996)
and recommended reading Papers of particular interest, published within the annual period of review, have been highlighted as: @BULLET of special interest @BULLET@BULLET of outstanding interest
Disruption of the β - sarcoglycan gene reveals pathogenetic complexity of limb - girdle muscular dystrophy type 2 E
R Cohn (2000)
10.1007/s004010050668
Concomitant deficiency of β- and γ-sarcoglycans in 20 α-sarcoglycan (adhalin)-deficient patients: immunohistochemical analysis and clinical aspects
R. Barresi (1997)
10.1006/MTHE.1999.0019
Rescue of skeletal muscles of gamma-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer.
L. Cordier (2000)
Mutant @BULLET@BULLET glycosyltransferase and altered glycosylation of α α-dystroglycan in the myodystrophy mouse
P Grewal (2001)
10.1038/NG0593-77
An alternative dystrophin transcript specific to peripheral nerve
T. Byers (1993)
10.1038/338259A0
Association of dystrophin and an integral membrane glycoprotein
K. Campbell (1989)
10.1002/(SICI)1097-4598(199904)22:4<517::AID-MUS14>3.0.CO;2-6
Dystrophin and utrophin do not play crucial roles in nonmuscle tissues in mice
J. A. Rafael (1999)
10.1038/NG1197-318
Absence of integrin α7 causes a novel form of muscular dystrophy
U. Mayer (1997)
10.1083/JCB.148.4.801
The Small Leucine-Rich Repeat Proteoglycan Biglycan Binds to α-Dystroglycan and Is Upregulated in Dystrophic Muscle
M. Bowe (2000)
10.1074/JBC.M007799200
Expression of γ-Sarcoglycan in Smooth Muscle and Its Interaction with the Smooth Muscle Sarcoglycan-Sarcospan Complex*
R. Barresi (2000)
10.2183/PJAB.76.22
Aquaporin-4 is absent at the sarcolemma and at perivascular astrocyte endfeet in α1-syntrophin knockout mice
T. Yokota (2000)
10.1038/12034
Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies
R. Grady (1999)
10.1128/MCB.20.5.1669-1677.2000
Sarcospan-Deficient Mice Maintain Normal Muscle Function
C. Lebakken (2000)
10.1073/PNAS.91.12.5572
Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse.
H. Xu (1994)
10.1038/NG0593-87
New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin
G. Cox (1993)
10.1101/GAD.10.10.1173
MyoD is required for myogenic stem cell function in adult skeletal muscle.
L. Megeney (1996)
10.1074/JBC.M100828200
Caveolin-3 Null Mice Show a Loss of Caveolae, Changes in the Microdomain Distribution of the Dystrophin-Glycoprotein Complex, and T-tubule Abnormalities*
F. Galbiati (2001)
10.1016/S0092-8674(00)81053-3
Interaction of Nitric Oxide Synthase with the Postsynaptic Density Protein PSD-95 and α1-Syntrophin Mediated by PDZ Domains
J. Brenman (1996)
Defective muscle basement membrane and lack of M - laminin in the dy / dy mouse
H Xu (1994)
10.1016/0092-8674(93)90615-W
Targeted disruption of the neuronal nitric oxide synthase gene
P. Huang (1993)
10.1038/355696A0
Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
O. Ibraghimov-Beskrovnaya (1992)
10.1038/352536A0
The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy
H. Stedman (1991)
10.1083/JCB.115.6.1685
Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice
K. Ohlendieck (1991)
10.1101/GAD.11.23.3143
Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture.
K. Andrä (1997)
10.1038/10165
Interactions between β2-syntrophin and a family of microtubule-associated serine/threonine kinases
C. Lumeng (1999)
E: Defective muscle basement membrane and lack of M-laminin in the dy/dy mouse
H Xu (1994)
10.1093/HMG/9.20.3047
Caveolin-3 deficiency causes muscle degeneration in mice.
Y. Hagiwara (2000)
10.1083/JCB.148.1.115
Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein
Terri G. Thompson (2000)
10.1038/75490
Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy
T. Klesert (2000)
10.1093/HMG/8.1.1
Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development.
R. Sarig (1999)
10.1093/HMG/8.10.1875
The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms.
K. Bushby (1999)
10.1038/NG1096-195
Autosomal recessive limbgirdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ–sarcoglycan gene
V. Nigro (1996)
10.1093/HMG/4.5.837
A novel dystrophin isoform is required for normal retinal electrophysiology.
V. N. D'Souza (1995)
10.1073/PNAS.81.4.1189
X chromosome-linked muscular dystrophy (mdx) in the mouse.
G. Bulfield (1984)
Non-muscle α α-dystroglycan is involved in epithelial development
M Durbeej (1995)
An interesting study showing that pharmacological intervention using oral treatment with verapamil is able to prevent cardiomyopathy in mice with disruption of the smooth muscle sarcoglycan complex
10.1038/13770
Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B
Reginald E. Bittner (1999)
Two isoforms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution
Me Adams (1993)
10.1016/S1534-5807(01)00070-3
Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1.
A. Yoshida (2001)
10.1093/HMG/3.8.1309
Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines.
J. Schofield (1994)
10.1038/NG0695-243
Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity
F. Piccolo (1995)
10.1083/JCB.130.1.79
Non-muscle alpha-dystroglycan is involved in epithelial development
M. Durbeej (1995)
10.1093/HMG/6.6.831
Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice.
R. Williamson (1997)
10.1126/SCIENCE.2662404
The molecular basis of muscular dystrophy in the mdx mouse: a point mutation.
P. Sicinski (1989)
10.1083/JCB.142.5.1279
γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin
A. A. Hack (1998)
10.1172/JCI3705
Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models.
Wenhua Kuang (1998)
10.1083/JCB.138.1.81
Differential Association of Syntrophin Pairs with the Dystrophin Complex
Matthew F. Peters (1997)
10.1074/JBC.270.20.11711
SH3 Domain-mediated Interaction of Dystroglycan and Grb2(*)
B. Yang (1995)
10.1016/0092-8674(94)90052-3
Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor
S. Gee (1994)
10.1016/0092-8674(94)90527-4
Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy
S. Roberds (1994)
Molecular and genetic characterization of sarcospan: insights into sarcoglycan–sarcospan domains
Rh Crosbie (2000)
10.1038/88865
Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse
P. K. Grewal (2001)
10.1083/JCB.151.7.1583
Loss of Calpain 3 Proteolytic Activity Leads to Muscular Dystrophy and to Apoptosis-Associated Iκbα/Nuclear Factor κb Pathway Perturbation in Mice
I. Richard (2000)
10.1126/SCIENCE.287.5455.989
Conservation and novelty in the evolution of cell adhesion and extracellular matrix genes.
H. Hutter (2000)
10.1083/JCB.145.1.153
Membrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan Subcomplex
R. Crosbie (1999)
10.1055/S-2007-973461
THE SAGA OF CONGENITAL MUSCULAR DYSTROPHY
F. M. Tomé (1999)
10.1073/PNAS.90.8.3710
Dystrophin protects the sarcolemma from stresses developed during muscle contraction.
B. Petrof (1993)
10.1038/35095054
An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy
J. Moll (2001)
10.1038/ng1195-257
β–sarcoglycan: characterization and role in limb–girdle muscular dystrophy linked to 4q12
L. E. Lim (1995)
10.1083/JCB.150.6.1385
Absence of α-Syntrophin Leads to Structurally Aberrant Neuromuscular Synapses Deficient in Utrophin
M. Adams (2000)
10.1016/S0092-8674(00)81975-3
Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle A Novel Mechanism for Cardiomyopathy and Muscular Dystrophy
R. Coral-Vázquez (1999)
Chimeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted monaural synapses
Pd Côté (1999)
Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle.
R. Cohn (1999)
10.1006/BBRC.2002.6608
Deficiency of α-Dystroglycan in Muscle–Eye–Brain Disease
H. Kano (2002)
10.1016/S0092-8674(00)80533-4
Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy
R. Grady (1997)



This paper is referenced by
10.1073/pnas.0802217105
Dystrophic skeletal muscle fibers display alterations at the level of calcium microdomains
M. DiFranco (2008)
10.1016/B978-1-4160-3285-4.10005-1
Muscle: Anatomy, Physiology, and Biochemistry
Jody A. Dantzig (2009)
Duchenne muscular dystrophy and fatty acid oxidation defect in a pediatric patient
Alejandra Acosta-Gualandri (2014)
10.1016/j.cell.2008.05.049
Highly Efficient, Functional Engraftment of Skeletal Muscle Stem Cells in Dystrophic Muscles
M. Cerletti (2008)
Ultrastructure of diaphragm from dystrophic α-sarcoglycan-null mice
A. Jakubiec-Puka (2005)
P2RX7 purinoceptor as a therapeutic target in Duchenne muscular dystrophy
R. Al-khalidi (2017)
10.1080/19490992.2016.1156284
Ankyrin-B in lens architecture and biomechanics: Just not tethering but more
P. V. Rao (2016)
Gene expression studies of pregastrulation development: the basement membrane is essential for cell differentiation
M. Åkerlund (2009)
10.1126/SCIENCE.1082254
Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts
M. Sampaolesi (2003)
10.1161/01.RES.0000041680.43270.F8
Dance Band on the Titanic: Biomechanical Signaling in Cardiac Hypertrophy
Mark A Sussman (2002)
10.1083/JCB.20051208507292013C
Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability
B. Gálvez (2013)
10.2217/14796678.2.4.467
Cytoskeletal basis of ion channel function in cardiac muscle.
M. Vatta (2006)
10.18632/AGING.100050
Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1
B. M. Scicchitano (2009)
10.1074/jbc.M410654200
The Phosphoinositol 3,4-Bisphosphate-binding Protein TAPP1 Interacts with Syntrophins and Regulates Actin Cytoskeletal Organization*
A. Hogan (2004)
10.1002/iub.72
Redox regulation of skeletal muscle
M. Jackson (2008)
10.1186/2044-5040-4-13
Absence of γ-sarcoglycan alters the response of p70S6 kinase to mechanical perturbation in murine skeletal muscle
C. Moorwood (2014)
10.1016/j.ajpath.2013.11.017
Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
K. Gawlik (2014)
Engineering and optimisation of mini-dystrophin constructs for Duchenne muscular dystrophy gene therapy
M. Reza (2015)
10.1016/j.bbrc.2010.05.021
Mouse model of skeletal muscle adiposity: a glycerol treatment approach.
D. Pisani (2010)
10.1371/journal.pone.0004759
Blastocyst Injection of Wild Type Embryonic Stem Cells Induces Global Corrections in Mdx Mice
Elizabeth Stillwell (2009)
Thérapie génique de la dystrophie musculaire de duchenne : utilisation de transgènes de la dystrophine chez le modèle canin
Christophe Pichavant (2010)
10.5451/UNIBAS-005653971
Mechanotransduction in fibroblasts
Michaela Brosig (2011)
10.1093/hmg/ddu194
Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin-/- mice.
A. Lu (2014)
10.1016/j.nmd.2008.05.017
Clinical and molecular overlap between myopathies and inherited connective tissue diseases
N. Voermans (2008)
10.1097/PHM.0b013e3181a5a24f
Dysregulated Intracellular Signaling and Inflammatory Gene Expression During Initial Disease Onset in Duchenne Muscular Dystrophy
N. P. Evans (2009)
10.1016/j.biotechadv.2007.11.003
Agrin and neuregulin, expanding roles and implications for therapeutics.
S. Williams (2008)
Uncovering the complexity of muscular dystrophy pathology through disease signaling
E. Wissing (2014)
10.1073/PNAS.0401944101
Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for the progression of cardiac dysfunction.
T. Toyo-Oka (2004)
10.1201/9781420039627.CH10
Animal Models for Muscular Disorders
Dominic Wells (2004)
10.1089/ars.2016.6782
Redox Control of Skeletal Muscle Regeneration.
E. Le Moal (2017)
Markers of degeneration and regeneration in Duchenne muscular dystrophy.
E. Abdel-Salam (2009)
10.1016/J.YEXCR.2004.09.007
CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophy.
L. Ségalat (2005)
See more
Semantic Scholar Logo Some data provided by SemanticScholar